• New NBDF CEO, Phil Gattone

  • Apr 12 2024
  • Duración: 39 m
  • Podcast

New NBDF CEO, Phil Gattone  Por  arte de portada

New NBDF CEO, Phil Gattone

  • Resumen

  • We have newly appointed NBDF CEO, Phil Gattone with us sharing his background and his vision for the organization and community. And, we have the story of the first commercially dosed patient of hemophilia B gene therapy. Hear from Jamison Buxton, the father of the patient…who also happens to be the director of the HTC.



    Show Notes:

    Subscribe:

    The BloodStream Podcast

    Presenting Sponsor:

    Takeda, visit bleedingdisorders.com to learn more.

    It’s a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.

    Connect with BloodStream Media:

    BloodStreamMedia.com

    BloodStream on Facebook

    BloodStream on Twitter

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre New NBDF CEO, Phil Gattone

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.